Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03803410
What this trial is testing

Surveillance of HCV in Uremics and Linking to Medical Care

Who this might be right for
Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 2,973
Post-approval studies (Phase 4)WithdrawnNCT03623568
What this trial is testing

Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant

Who this might be right for
Kidney FailureKidney DiseasesHepatitis C
Raymond T. Chung, MD
Large-scale testing (Phase 3)Study completedNCT01732796
What this trial is testing

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 470
Post-approval studies (Phase 4)Study completedNCT02804386
What this trial is testing

Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

Who this might be right for
Hepatitis C, Chronic
PharmEvo Pvt Ltd 573
Not applicableStudy completedNCT02537379
What this trial is testing

Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 552
Testing effectiveness (Phase 2)Study completedNCT01825980
What this trial is testing

Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C
Novartis Pharmaceuticals 54
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Large-scale testing (Phase 3)Study completedNCT02247401
What this trial is testing

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Who this might be right for
HCVHepatitis C InfectionGenotype 4
AbbVie 160
Post-approval studies (Phase 4)Ended earlyNCT00255034
What this trial is testing

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 146
Not applicableUnknownNCT04004299
What this trial is testing

Self-testing for HCV Re-infection in MSM

Who this might be right for
Hepatitis C RecurrentHIV-1-infection
Erasmus Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT02421211
What this trial is testing

Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Sciences Ireland UC 41
Not applicableEnded earlyNCT04057001
What this trial is testing

Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study

Who this might be right for
Liver Transplant; ComplicationsHepatitis C
Yale University 49
Not applicableLooking for participantsNCT06179498
What this trial is testing

Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs

Who this might be right for
Hepatitis C
University of California, San Francisco 500
Not applicableUnknownNCT06316492
What this trial is testing

A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Faculty of Medicine in Assiut and New Valley University to Assess Knowledge, Attitude ,and Practice of Rural Population in a Remote Governorate ( New Valley ) Towards Hepatitis B and C Viruses

Who this might be right for
Hepatitis BHepatitis C
Assiut University 450
Post-approval studies (Phase 4)Study completedNCT00830609
What this trial is testing

High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3

Who this might be right for
Chronic Hepatitis C
Dr. Conrado Fernandez 101
Large-scale testing (Phase 3)Ended earlyNCT02319200
What this trial is testing

Primary Prevention Hepatocellular Carcinoma by Metformin

Who this might be right for
Hepatocellular CarcinomaHepatitis C, ChronicCirrhosis
Assistance Publique - Hôpitaux de Paris 11
Testing effectiveness (Phase 2)Study completedNCT00787371
What this trial is testing

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 69
Testing effectiveness (Phase 2)Study completedNCT02457611
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

Who this might be right for
Hepatitis C Infection With HIV Co-Infection
Gilead Sciences 26
Testing effectiveness (Phase 2)Ended earlyNCT03827200
What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionAscites
Noorik Biopharmaceuticals AG 19
Post-approval studies (Phase 4)Ended earlyNCT03208244
What this trial is testing

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant

Who this might be right for
End Stage Heart DiseaseHepatitis C
Massachusetts General Hospital 40
Next Page